U.S. markets open in 2 hours 56 minutes
  • S&P Futures

    3,628.25
    -4.50 (-0.12%)
     
  • Dow Futures

    29,932.00
    -66.00 (-0.22%)
     
  • Nasdaq Futures

    12,097.25
    +21.25 (+0.18%)
     
  • Russell 2000 Futures

    1,847.70
    -3.80 (-0.21%)
     
  • Crude Oil

    45.42
    +0.51 (+1.14%)
     
  • Gold

    1,806.30
    +1.70 (+0.09%)
     
  • Silver

    23.39
    +0.09 (+0.39%)
     
  • EUR/USD

    1.1888
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    22.08
    -0.58 (-2.56%)
     
  • GBP/USD

    1.3326
    -0.0033 (-0.25%)
     
  • USD/JPY

    104.4700
    -0.0100 (-0.01%)
     
  • BTC-USD

    19,254.37
    +400.38 (+2.12%)
     
  • CMC Crypto 200

    382.49
    +12.74 (+3.44%)
     
  • FTSE 100

    6,398.60
    -33.57 (-0.52%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers

Rigrodsky & Long, P.A.
·2 min read

WILMINGTON, Del., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

HD Supply Holdings, Inc. (NASDAQ GS: HDS) regarding possible breaches of fiduciary duties and other violations of law related to HD Supply’s agreement to be acquired by The Home Depot, Inc. Under the terms of the agreement, HD Supply’s shareholders will receive $56.00 per share in cash. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-hd-supply-holdings-inc.

Urovant Sciences Ltd. (NASDAQ GS: UROV) regarding possible breaches of fiduciary duties and other violations of law related to Urovant’s agreement to be acquired by Sumitovant Biopharma Ltd. Under the terms of the agreement Urovant’s shareholders will receive $16.25 per share in cash. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-urovant-sciences-ltd.

Akers Biosciences, Inc. (NASDAQ GS: AKER) regarding possible breaches of fiduciary duties and other violations of law related to Akers Biosciences’ agreement to merge with MYMD Pharmaceuticals, Inc. Under the terms of the agreement, Akers Biosciences will issue a number of shares of Akers Biosciences’ common stock to shareholders of MYMD. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-akers-biosciences-inc.

Tengasco, Inc. (NYSE: TGC) regarding possible breaches of fiduciary duties and other violations of law related to Tengasco’s agreement to merge with Riley Exploration – Permian, LLC. Under the terms of the agreement, Tengasco will issue 97.796467 shares of Tengasco common stock to each shareholder of Riley Exploration. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-tengasco-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com